Evidence map›Paper›PMID 36982797›Full record

ArticleInternational journal of molecular sciences2023

Investigating Circular RNAs Using qRT-PCR; Roundup of Optimization and Processing Steps.

Rares Drula, Cornelia Braicu, Sergiu Chira, Ioana Berindan-Neagoe

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Discovery of a Novel Shared Variant AmongInternational journal of genomics · 2024
    Article
  8. Virus-Encoded Circular RNAs: Role and Significance in Viral Infections.International journal of molecular sciences · 2023
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Rares DrulaResearch Center for Functional Genomics, Biomedicine and Translational Medicine, "Iuliu Haţieganu" University of Medicine and Pharmacy, 15 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
Cornelia BraicuResearch Center for Functional Genomics, Biomedicine and Translational Medicine, "Iuliu Haţieganu" University of Medicine and Pharmacy, 15 Victor Babeș Street, 400012 Cluj-Napoca, Romania.ORCID 0000-0002-3055-4747
Sergiu ChiraResearch Center for Functional Genomics, Biomedicine and Translational Medicine, "Iuliu Haţieganu" University of Medicine and Pharmacy, 15 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
Ioana Berindan-NeagoeResearch Center for Functional Genomics, Biomedicine and Translational Medicine, "Iuliu Haţieganu" University of Medicine and Pharmacy, 15 Victor Babeș Street, 400012 Cluj-Napoca, Romania.ORCID 0000-0001-5828-1325
Iuliu Hațieganu University of Medicine and Pharmacy · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circular RNAs (circRNAs) have gained recent attraction due to their functional versatility and particular structure connected to human diseases. Current investigations are focused on the interplay between their ability to sponge smaller species of RNAs, such as microRNAs (miRNAs), thus influencing their regulatory activity on gene expression and protein templates. Therefore, their reported implication in various biological processes axis has resulted in an accumulating number of studies. While the testing and annotation methods of novel circular transcripts are still under development, there is still a plethora of transcript candidates suitable for investigation in human disease. The discordance in the literature regarding the approaches used in circRNAs quantification and validation methods, especially regarding qRT-PCR, the current golden standard procedure, leads to high result variability and undermines the replicability of the studies. Therefore, our study will offer several valuable insights into bioinformatic data for experimental design for circRNA investigation and in vitro aspects. Specifically, we will highlight key aspects such as circRNA database annotation divergent primer design and several processing steps, such as RNAse R treatment optimization and circRNA enrichment assessment. Additionally, we will provide insights into the exploration of circRNA-miRNA interactions, a prerequisite for further functional investigations. With this, we aim to contribute to the methodological consensus in a currently expanding field with possible implications for assessing therapeutic targets and biomarker discovery.

Indexed as

MicroRNAsRNA, CircularComputational BiologyGene Expression ProfilingGene Regulatory NetworksHumansPolymerase Chain ReactionMicroRNAsRNA, CircularcircRNAsmiRNAsRNAse R

Identifiers

PMID36982797
PMCPMC10056686
OpenAlexW4327737078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.